$CHWY

Chewy's stock fell 10.92% in a week despite Q2 revenue growth and raised guidance. Investors worry about slower revenue, cautious pet spending, and nonrecurring margin boosts. Analysts maintain Buy ratings. Chewy filed a shelf registration for future financing.

Chewy (CHWY) and Petco (WOOF) reported stronger sales in cat products and weaker dog-related sales. General Mills (GIS) saw similar trends, with cat food sales up and dog food down. Cat ownership grew faster than dog ownership, with cats costing less overall. Chewy's Q2 sales rose 7.3% YoY, and it raised full-year guidance, but its stock is down 43.72% YTD.

Cat food and product sales are rising, boosting retailers like General Mills (GIS), Chewy (CHWY), and Petco (WOOF). According to the companies, cat ownership increased 5% in 2025, driving demand. General Mills reported double-digit growth in cat food sales, while dog food sales declined. Chewy and Petco also noted strong cat product sales in their recent earnings calls.

Chewy (CHWY) shares fell 24.9% in a month, with valuation near a five-year low. Q2 net sales rose 7.3% to $3.33B, but earnings estimates dropped 3.6%. Autoship sales grew 9.3%, and active customers reached 21.7M. Margin normalization and consumer pressure pose risks, according to the company.

Chewy (CHWY) and Petco (WOOF) presented at a Goldman Sachs event, highlighting growth strategies. Chewy emphasized its platform expansion, including health services, while Petco focused on its turnaround progress. Both companies aim to move beyond transactional sales. Chewy's stock has faced recent downgrades, while Petco's turnaround is in its early stages. Investors should monitor Chewy's diversification and Petco's sales trends.

Chewy (CHWY) reported Q2 net sales of $3.33B, up 7.3% YoY, and adjusted EPS of $0.36, exceeding estimates. The company raised its full-year outlook but noted soft pet spending. Autoship sales grew 9.3% YoY, and Chewy Health saw triple-digit revenue growth. Profitability included one-time benefits, and organic growth slowed to 5.7%. Hedge fund interest declined.

Chewy expects AI to reduce costs by $50M in fiscal 2027, up from low tens of millions this year. CEO Sumit Singh attributes savings to AI tools in customer service, pharmacy, and veterinary care. The company's AI assistant, Cai, handles 30% of chats without human agents. AI tools also improve internal operations and pharmacy processes. Chewy built the AI infrastructure in-house, giving it a competitive advantage. The savings will offset wage inflation and fund growth initiatives.

Chewy (CHWY) filed a shelf registration, allowing it to raise capital flexibly in the future. Analysts' long-term forecasts for the company vary widely. The article is not financial advice and does not consider recent price-sensitive announcements.

Chewy estimates $50M in annual cost savings from AI initiatives by 2027, according to its earnings call. The company uses AI for advertising, customer care, and pharmacy services, aiming to reduce costs and improve productivity. Net sales rose 7.3% to $3.33B, with active customers increasing 3.8%. Chewy's AI assistant, Cai, is used in nearly one-third of orders and returns. The company plans to introduce a redesigned loyalty program with health benefits.

Chewy (NYSE:CHWY) reports stable pet adoption trends, with strong growth in health services. The company targets 150,000-250,000 net active-customer additions and high-single to low-double-digit revenue growth. Chewy's pharmacy and 60 veterinary clinics are outperforming expectations, with plans to expand through acquisitions and AI tools. Autoship and app engagement drive higher order values. Chewy aims to self-fund growth initiatives and prioritize acquisitions in health.